Speaker
Description
Gut microbiota plays an important role in the onset of cancer, immunological, neurodegenerative, gastrointestinal, metabolic disorders. The goal of reversing an established microbial dysbiosis is mainly done through various innovative approaches like Probiotics, prebiotics, postbiotics, antibiotics, and fecal microbiota transplantation. Although it should be emphasized that there are concerns and problems associated with these approaches that may result in clinical consequences. The genetic revolution promises to change the way clinicians treat patients by customizing treatment, lowering complication rates, and cutting costs. Using next-generation sequencing, we are now able to characterize the microbial community, which involves all the microbes that live inside and over our body as well as all their genetic components. This enables us to take this significant cause of human disease into account when creating new preventive and therapeutic approaches. Characterizing the distinctive metabolic patterns of each patient appears like a realistic strategy regarding complicated metabolic patterns linked with various diseases. One can picture a time when consistently studying the microbiota enables us to anticipate unique reactions to various meals and medications. Furthermore, a deeper comprehension of the human microbiome can inspire the creation of new treatment plans for various diseases. In the age of customized medicine, it makes sense to consider potential therapeutic agents including dietary changes, fecal microbiota implantation, and individually tailored probiotic and prebiotic supplements that may be utilized to alter the gut microbiome.
Keywords: personalized medicine, gut, microbiota, probiotics, prebiotics, postbiotics.